Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial - PubMed (original) (raw)
Clinical Trial
Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial
G Bleichner et al. Intensive Care Med. 1997 May.
Abstract
Objective: To assess the preventive effect of Saccharomyces boulardii on diarrhea in critically ill tube-fed patients and to evaluate risk factors for diarrhea.
Design: Prospective, multicenter, randomized, double-blind placebo-controlled study.
Setting: Eleven intensive care units in teaching and general hospitals.
Patients: Critically ill patients whose need for enteral nutrition was expected to exceed 6 days.
Intervention: S. boulardii 500 mg four times a day versus placebo.
Measurements and results: Diarrhea was defined by a semiquantitative score based on the volume and consistency of stools. A total of 128 patients were studied, 64 in each group. Treatment with S. boulardii reduced the mean percentage of days with diarrhea per feeding days from 18.9 to 14.2% [odds ratio (OR) = 0.67, 95% confidence interval (CI) = 0.50-0.90, P = 0.0069]. In the control group, nine risk factors were significantly associated with diarrhea: nonsterile administration of nutrients in open containers, previous suspension of oral feeding, malnutrition, hypoalbuminemia, sepsis syndrome, multiple organ failure, presence of an infection site, fever or hypothermia, and use of antibiotics. Five independent factors were associated with diarrhea in a multivariate analysis: fever or hypothermia, malnutrition, hypoalbuminemia, previous suspension of oral feeding, and presence of an infection site. After adjustment for these factors, the preventive effect of S. boulardii on diarrhea was even more significant (OR = 0.61, 95% CI = 0.44-0.84, P < 0.0023).
Conclusions: S. boulardii prevents diarrhea in critically ill tube-fed patients, especially in patients with risk factors for diarrhea.
Similar articles
- Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial.
Pozzoni P, Riva A, Bellatorre AG, Amigoni M, Redaelli E, Ronchetti A, Stefani M, Tironi R, Molteni EE, Conte D, Casazza G, Colli A. Pozzoni P, et al. Am J Gastroenterol. 2012 Jun;107(6):922-31. doi: 10.1038/ajg.2012.56. Epub 2012 Apr 3. Am J Gastroenterol. 2012. PMID: 22472744 Clinical Trial. - [A multicenter randomized controlled study of Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in infants and young children].
Wan CM, Yu H, Liu G, Xu HM, Mao ZQ, Xu Y, Jin Y, Luo RP, Wang WJ, Fang F. Wan CM, et al. Zhonghua Er Ke Za Zhi. 2017 May 4;55(5):349-354. doi: 10.3760/cma.j.issn.0578-1310.2017.05.008. Zhonghua Er Ke Za Zhi. 2017. PMID: 28482385 Clinical Trial. Chinese. - Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: a prospective, double-blind, randomized, and controlled trial.
Spapen H, Diltoer M, Van Malderen C, Opdenacker G, Suys E, Huyghens L. Spapen H, et al. Clin Nutr. 2001 Aug;20(4):301-5. doi: 10.1054/clnu.2001.0399. Clin Nutr. 2001. PMID: 11478826 Clinical Trial. - Diarrhoea in the critically ill.
Wiesen P, Van Gossum A, Preiser JC. Wiesen P, et al. Curr Opin Crit Care. 2006 Apr;12(2):149-54. doi: 10.1097/01.ccx.0000216583.64804.46. Curr Opin Crit Care. 2006. PMID: 16543792 Review. - Fiber and prebiotic supplementation in enteral nutrition: A systematic review and meta-analysis.
Kamarul Zaman M, Chin KF, Rai V, Majid HA. Kamarul Zaman M, et al. World J Gastroenterol. 2015 May 7;21(17):5372-81. doi: 10.3748/wjg.v21.i17.5372. World J Gastroenterol. 2015. PMID: 25954112 Free PMC article. Review.
Cited by
- Editorial of Special Issue "Human Pathogenic Fungi: Host-Pathogen Interactions and Virulence".
Jawhara S. Jawhara S. Microorganisms. 2023 Apr 7;11(4):963. doi: 10.3390/microorganisms11040963. Microorganisms. 2023. PMID: 37110386 Free PMC article. - Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children.
Goldenberg JZ, Yap C, Lytvyn L, Lo CK, Beardsley J, Mertz D, Johnston BC. Goldenberg JZ, et al. Cochrane Database Syst Rev. 2017 Dec 19;12(12):CD006095. doi: 10.1002/14651858.CD006095.pub4. Cochrane Database Syst Rev. 2017. PMID: 29257353 Free PMC article. - Enteral nutrition and mucosal immunity: implications for feeding strategies in surgery and trauma.
Sigalet DL, Mackenzie SL, Hameed SM. Sigalet DL, et al. Can J Surg. 2004 Apr;47(2):109-16. Can J Surg. 2004. PMID: 15132464 Free PMC article. Review. - Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism.
Cassone M, Serra P, Mondello F, Girolamo A, Scafetti S, Pistella E, Venditti M. Cassone M, et al. J Clin Microbiol. 2003 Nov;41(11):5340-3. doi: 10.1128/JCM.41.11.5340-5343.2003. J Clin Microbiol. 2003. PMID: 14605200 Free PMC article. Review. - Efficacy of saccharomyces boulardii with antibiotics in acute amoebiasis.
Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A. Mansour-Ghanaei F, et al. World J Gastroenterol. 2003 Aug;9(8):1832-3. doi: 10.3748/wjg.v9.i8.1832. World J Gastroenterol. 2003. PMID: 12918131 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical